Home > Financial Ratios > SEQUENT SCIENTIFIC

SEQUENT SCIENTIFIC
Core EBITDA Growth

    Back to All Ratios
SEQUENT SCIENTIFIC is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for SEQUENT SCIENTIFIC
Please provide your vote to see the results

SEQUENT SCIENTIFIC Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 294.50-84.74-45.4522.1835.03

What is the latest Core EBITDA Growth ratio of SEQUENT SCIENTIFIC ?

The latest Core EBITDA Growth ratio of SEQUENT SCIENTIFIC is 294.50 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar2024294.50
Mar2023-84.74
Mar2022-45.45
Mar202122.18
Mar202035.03

How is Core EBITDA Growth of SEQUENT SCIENTIFIC Trending?

Years Core EBITDA Growth % Change
Mar2024 294.5
Positive
Mar2023 -84.74
Negative
Mar2022 -45.45
Negative
Mar2021 22.18
-36.68
Mar2020 35.03 -

Other Financial Ratios of SEQUENT SCIENTIFIC


Compare Core EBITDA Growth ratio of peers of SEQUENT SCIENTIFIC

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SEQUENT SCIENTIFIC ₹3,581.8 Cr -5.8% -9.6% 19.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹397,246.0 Cr 4.7% -5.4% 0.5% Stock Analytics
DIVIS LABORATORIES ₹147,119.0 Cr 0.5% -9.8% 55.5% Stock Analytics
CIPLA ₹116,805.0 Cr 2% -1.8% -1.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹103,554.0 Cr 2.6% -6.1% 14% Stock Analytics
DR REDDYS LABORATORIES ₹93,192.0 Cr -0.9% -10% -11.3% Stock Analytics


SEQUENT SCIENTIFIC Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SEQUENT SCIENTIFIC

-5.8%

-9.6%

19.1%

SENSEX

1.5%

-5.1%

0.6%


You may also like the below Video Courses